Darapladib

From Self-sufficiency
Jump to: navigation, search
Darapladib
File:Darapladib structure.svg
Systematic (IUPAC) name
N-(2-diethylaminoethyl)-2-[2-[(4-fluorophenyl)methylsulfanyl]-4-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-1-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide
Identifiers
CAS Number 356057-34-6
ATC code none
PubChem CID 9939609
Chemical data
Formula C36H38F4N4O2S
Molar mass 666.77 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.Darapladib is a drug used to inhibit lipoprotein-associated phospholipase A2 (lp-PLA2).

As of March 2008, it is being studied as a possible add-on treatment for atherosclerosis.[1][2][3][4]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links


Stub icon This pharmacology-related article is a stub. You can help ssf by expanding it.
  1. ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  2. ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  3. ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  4. ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Darapladib&oldid=23616"